Literature DB >> 2832478

Efficient purification of Epstein-Barr virus membrane antigen gp340 by fast protein liquid chromatography.

E M David1, A J Morgan.   

Abstract

A rapid and efficient procedure for the isolation of Epstein-Barr (EB) virus membrane glycoprotein gp340 has been developed. The mild, two step method consisted of anion exchange chromatography of B95-8 cell membrane detergent extracts followed by further purification by gel filtration. Production of homogeneous gp340 was achieved routinely with recoveries of at least 35% from starting material. The purified molecule, when injected into mice with a synthetic muramyl dipeptide adjuvant, N-acetylmuramyl-L-threonyl-D-isoglutamine ((Thr1)MDP), elicited high titres of EB virus-neutralizing antibody.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2832478     DOI: 10.1016/0022-1759(88)90424-3

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  6 in total

Review 1.  Control of viral disease: the development of Epstein-Barr virus vaccines.

Authors:  A J Morgan
Journal:  Springer Semin Immunopathol       Date:  1991

2.  Epithelial cell polarization is a determinant in the infectious outcome of immunoglobulin A-mediated entry by Epstein-Barr virus.

Authors:  Y J Gan; J Chodosh; A Morgan; J W Sixbey
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

3.  Identification of two T-cell epitopes on the candidate Epstein-Barr virus vaccine glycoprotein gp340 recognized by CD4+ T-cell clones.

Authors:  L E Wallace; J Wright; D O Ulaeto; A J Morgan; A B Rickinson
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

4.  Epstein-Barr virus (EBV) antigens processed and presented by B cells, B blasts, and macrophages trigger T-cell-mediated inhibition of EBV-induced B-cell transformation.

Authors:  M T Bejarano; M G Masucci; A Morgan; B Morein; G Klein; E Klein
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

5.  Four Decades of Prophylactic EBV Vaccine Research: A Systematic Review and Historical Perspective.

Authors:  Gabriela M Escalante; Lorraine Z Mutsvunguma; Murali Muniraju; Esther Rodriguez; Javier Gordon Ogembo
Journal:  Front Immunol       Date:  2022-04-14       Impact factor: 8.786

6.  Characterization of an Epstein-Barr virus receptor on human epithelial cells.

Authors:  M Birkenbach; X Tong; L E Bradbury; T F Tedder; E Kieff
Journal:  J Exp Med       Date:  1992-11-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.